Skip to main content
TipRanks
Go Ultimate75% OFF

Hims & Hers Health (82W) Stock Price & Analysis

38 Followers

82W Stock Chart & Stats

€17.75-€0.49(-2.69%)
At close: 5:30 PM GMT+1
€20€25Aug 17Aug 31Sep 14Sep 28Oct 12Oct 27Nov 9
Day’s Range
EUR 17.58 - EUR 18.05
52-Week Range
EUR 11.82 - EUR 35.25
Previous Close
EUR 18.24
Volume
N/A
Average Volume (3M)
2,426
Market Cap
EUR 4.20B
Enterprise Value
EUR 7.81B
Total Cash (Recent Filing)
EUR 712.22M
Total Debt (Recent Filing)
EUR 1.56B
Price to Earnings (P/E)
―
Beta
1.37
Next Earnings
Mar 01, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Rapid Revenue Growth

Strong and accelerating revenue growth indicates expanding demand for the company’s digital health platform and treatment categories. Sustained top-line momentum can improve operating leverage, fund product investment, and reinforce Hims & Hers’ position as its customer base and geographic reach expand.

Scale And International Expansion

A large, growing customer base gives the platform meaningful scale across acquisition, care delivery, and fulfillment. Expansion across four continents and continued subscriber growth broaden the addressable market, diversify revenue sources, and create a stronger foundation for recurring consumer relationships.

Cash Generation And Liquidity

Positive free cash flow and substantial cash and investments provide resources to support product development, international expansion, and operational investment without relying solely on external financing. This liquidity also gives management greater flexibility while the business scales into new specialties and markets.

Bears Say

Elevated Leverage

The sharp increase in leverage and smaller equity cushion raise financial risk as the company continues investing and navigating earnings volatility. A more aggressive capital structure can restrict strategic flexibility, increase financing sensitivity, and make weaker operating periods more difficult to absorb.

Profitability And Margin Pressure

The return to a GAAP loss, alongside lower gross margins, shows that rapid growth is not currently translating consistently into bottom-line profitability. Margin pressure from branded weight loss products and international expansion could limit earnings conversion and make future results more dependent on execution.

Subscriber Growth Headwinds

Sequential subscriber contraction creates a near-term risk to the recurring-revenue model, particularly if reduced marketing investment continues to slow customer additions. Although the annual subscriber base is growing, sustained acquisition or retention pressure could weaken growth efficiency and delay operating leverage.

Hims & Hers Health News

82W FAQ

What was Hims & Hers Health’s price range in the past 12 months?
Hims & Hers Health lowest stock price was €11.82 and its highest was €35.25 in the past 12 months.
What is Hims & Hers Health’s market cap?
Hims & Hers Health’s market cap is €4.20B.
When is Hims & Hers Health’s upcoming earnings report date?
Hims & Hers Health’s next earnings report is estimated for Mar 01, 2027 (not yet confirmed), which is in 104 days.
How were Hims & Hers Health’s earnings last quarter?
Hims & Hers Health released its earnings results on Nov 09, 2026. The company reported -€0.127 earnings per share for the quarter, missing the consensus estimate of €0.051 by -€0.177.
Is Hims & Hers Health overvalued?
According to Wall Street analysts Hims & Hers Health’s price is currently Undervalued.
Does Hims & Hers Health pay dividends?
Hims & Hers Health does not currently pay dividends.
What is Hims & Hers Health’s EPS estimate?
Hims & Hers Health’s EPS estimate is -0.02.
How many shares outstanding does Hims & Hers Health have?
Hims & Hers Health has 226,034,800 shares outstanding.
What happened to Hims & Hers Health’s price movement after its last earnings report?
Hims & Hers Health reported an EPS of -€0.127 in its last earnings report, missing expectations of €0.051. Following the earnings report the stock price went down -20.431%.
Which hedge fund is a major shareholder of Hims & Hers Health?
Hedge funds hold Hims & Hers Health shares: the largest hedge-fund position in Hims & Hers Health is 1,314,745,028 shares, and hedge funds decreased their holdings by 81.4K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology